Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgical Innovations GroupLSE:SUN Return-on-Tangible-Asset is -29.92% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Surgical Innovations Group ranks worse than 68.3% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Surgical Innovations Group's annualizedNet Income for the quarter that ended in Dec. 2025 was £-1.83 Mil. Surgical Innovations Group's average total tangible assets for the quarter that ended in Dec. 2025 was £6.12 Mil. Therefore, Surgical Innovations Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was -29.92%.
The historical rank and industry rank for Surgical Innovations Group's Return-on-Tangible-Asset or its related term are showing as below:
LSE:SUN'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -34.73 Med: -5.32 Max: 12.3
Current: -14.09
During the past 13 years, Surgical Innovations Group's highest Return-on-Tangible-Asset was 12.30%. The lowest was -34.73%. And the median was -5.32%.
LSE:SUN's Return-on-Tangible-Asset is ranked worse than 68.3% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs LSE:SUN: -14.09
Surgical Innovations Group (LSE:SUN) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Surgical Innovations Group Return-on-Tangible-Asset Related Terms
Surgical Innovations Group Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group Return-on-Tangible-Asset Chart
LSE:SUN vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Surgical Innovations Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -29.92% mean?
Surgical Innovations Group (LSE:SUN) has a Return-on-Tangible-Asset of -29.92% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Surgical Innovations Group and its competitors. According to the industry distribution chart, Surgical Innovations Group ranks #584 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 68.3%.
Is Surgical Innovations Group's Return-on-Tangible-Asset too high?
Surgical Innovations Group's current Return-on-Tangible-Asset is -29.92%. Based on the distribution chart, Surgical Innovations Group ranks #584 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Surgical Innovations Group's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #584 out of 855 companies for Return-on-Tangible-Asset. This places Surgical Innovations Group in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.56, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current Return-on-Tangible-Asset is -29.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Surgical Innovations Group (LSE:SUN) has a current Return-on-Tangible-Asset of -29.92%. The current Return-on-Tangible-Asset is -29.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Return-on-Tangible-Asset is -29.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 
